IBA Quasar
IBA Quasar is the radiation-therapy quality-assurance product brand of IBA Dosimetry GmbH, supplying advanced phantoms and software for medical physicists to calibrate, align, and validate radiotherapy and medical imaging systems across 3,000+ treatment centers in 125+ countries.
- Company typePublic
- Founded2000
- HeadquartersLondon, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What IBA Quasar does
IBA Quasar is a product brand of physical and software quality-assurance tools for radiation therapy, owned and operated by IBA Dosimetry GmbH, a subsidiary of publicly listed IBA Group (Euronext Brussels: IBA). The QUASAR line consists of advanced phantoms (patient and motion simulators) and reference software used by medical physicists to calibrate, align, and validate radiotherapy delivery and imaging systems, with particular depth in MR-guided radiotherapy (MR-Sim and MR-Linac), IGRT, motion management, IMRT, 3D dosimetry, and image distortion analysis for Gamma Knife platforms. Named SKUs include the Motion MR Platform, MRgRT Insight Phantom, MRI4D Motion Phantom, MRID3D, pRESP 2.0, Platform HD, Penta-Guide Phantom, and GRID3D Advantage.
The franchise serves hospitals, cancer clinics, and radiation therapy centers worldwide, with cited deployments across 3,000+ premier treatment centers and 10,000+ users in 125+ countries, supported by an enterprise field-sales model, the ICC International Competence Center training program, and QA-plus support services. Revenue mechanics are predominantly specialized hardware sales bundled with software and services to clinical buyers; no public pricing or per-unit economics is disclosed. The brand carries a registered QUASAR trademark in the EU, UK, and US, and operates under the broader IBA Dosimetry portfolio rather than as a standalone P&L.
Corporate context: IBA Quasar/Modus QA was founded in 2000 and is reported to be based in London, Canada (per firmographics), while the trademark and product operations sit with IBA Dosimetry GmbH. IBA Group posted record FY 2025 revenue of €620M and a record €1.6B order book, providing indirect read-across to demand conditions, but no segment-level figures for IBA Dosimetry or QUASAR specifically are disclosed in the source data.
IBA Quasar firmographics
Firmographics- Name
- IBA Quasar
- Legal name
- IBA Dosimetry GmbH
- Website
- https://modusqa.com
- Company type
- Public
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IBA Quasar is the radiation-therapy quality-assurance product brand of IBA Dosimetry GmbH, supplying advanced phantoms and software for medical physicists to calibrate, align, and validate radiotherapy and medical imaging systems across 3,000+ treatment centers in 125+ countries.
- Ownership category
- akta.pro rank
IBA Quasar industry classification
Industry- Product category
- Radiation Therapy Quality Assurance
- NAICS
- Irradiation Apparatus Manufacturing (334517), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)
- akta.pro secondary industries
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Radiation Dose Management & Analytics (HLACALAH)
Keywords
Where IBA Quasar is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- Canada
- HQ region
- North America
Markets served
IBA Quasar business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Proton Therapy Systems: Record revenue driver with significant order intake and backlog. Part of IBA's multi-segment operations.
- Dosimetry and QA Equipment: Sale of QUASAR phantoms, software tools, and quality assurance solutions to radiation therapy centers worldwide
- Professional Services: ICC International Competence Center training and QA plus support services
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
IBA Quasar product offering
Product offeringCore offering
IBA Quasar designs and manufactures physical phantoms and accompanying software tools for quality assurance in radiation therapy. The QUASAR portfolio covers MR-guided radiotherapy planning, motion management, IGRT commissioning, IMRT, and geometric distortion analysis, and is sold to medical physicists at cancer treatment centers and hospitals worldwide.
Product overview
QUASAR is a comprehensive portfolio of radiation therapy quality assurance products under IBA Dosimetry, consisting of advanced phantoms and software tools deployed across more than 3000 premier treatment centers worldwide. The product line includes MR planning tools (Motion MR Platform, MRgRT Insight Phantom, MRI⁴ᴰ Motion Phantom, MRID³ᴰ), motion management solutions (pRESP 2.0, Platform HD, Penta-Guide Phantom), geometric distortion analysis (GRID³ᴰ Advantage), and machine targeting devices. These products support various treatment technologies including proton therapy, carbon therapy, flash therapy, adaptive radiotherapy, and SRS/SBRT, and are designed to work with major treatment systems such as C-ARM Linacs, CyberKnife, Cyclotron, Halcyon/Ethos, MR-Guided Radiotherapy, and Radixact.
Differentiator
Problem solved
Functional benefit
Brands
- QUASAR Motion MR Platform: Large, efficient motion phantom that can accommodate 45kg for MR-guided radiation therapy QA
- QUASAR MRgRT Insight Phantom
- QUASAR MRI4D Motion Phantom
- QUASAR MRID3D
- QUASAR pRESP 2.0
- QUASAR Platform HD
- QUASAR Penta-Guide Phantom
- QUASAR GRID3D Advantage
Products and services
- QUASAR Motion MR Platform Large, efficient motion phantom that can accommodate up to 45 kg, designed for QA of MR-guided radiation therapy systems.
- QUASAR MRgRT Insight Phantom All-in-one phantom for QA on MR-SIM and MR-LINAC systems, covering geometric distortion, image quality, and targeting testing.
- QUASAR MRI4D Motion Phantom MR-safe programmable motion phantom for testing and validating 4D treatment delivery protocols on MR-sim and MR-Linacs.
- QUASAR MRID3D Geometric Distortion Analysis System Geometric distortion analysis phantom and system for MR imaging quality assurance in radiation therapy planning.
- QUASAR pRESP 2.0 End-to-end phantom for motion management quality assurance in radiation therapy, including respiratory motion QA.
- QUASAR Platform HD Heavy-duty respiratory motion platform for simulating patient motion during QA of motion-guided radiation therapy systems.
- QUASAR Penta-Guide Phantom Phantom for commissioning and testing Image-Guided Radiation Therapy (IGRT) systems.
- QUASAR GRID3D Advantage Image distortion analysis phantom for Leksell Gamma Knife stereotactic radiosurgery platforms.
Quantifiable outcome
- Deployed across 3000+ premier treatment centers worldwide
- +2 more outcomes
Companies that use IBA Quasar
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
IBA Quasar technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
IBA Quasar partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
IBA Quasar competitors and assessment
Company assessmentDirect peers
- CIRS (Computerized Imaging Reference Systems): CIRS manufactures tissue-equivalent phantoms and QA tools used across radiation therapy and diagnostic imaging. Its phantoms and imaging QA products compete with QUASAR's geometric distortion, motion, and image QA phantoms.
- Sun Nuclear (Mirion Medical): Sun Nuclear is the closest direct competitor to QUASAR in radiation therapy quality assurance, offering phantoms, dosimetry, and patient QA software to medical physicists. Both vendors compete head-to-head for commissioning, machine QA, and patient QA budgets at treatment centers worldwide.
- Standard Imaging: Standard Imaging provides QA phantoms, electrometers, and software for radiation therapy. It overlaps with QUASAR in IMRT/VMAT QA, brachytherapy QA, and patient-specific QA delivered to medical physicists at treatment centers.
- PTW Dosimetry: PTW is a leading independent vendor of RT QA and dosimetry equipment, including ionization chambers, detectors, and phantoms. It competes directly with QUASAR in patient dosimetry, machine QA, and detector-based QA for photon and proton therapy.
Broad incumbents
- Varian (Siemens Healthineers): Varian, now part of Siemens Healthineers, is a major linac and radiation oncology software vendor. Its Eclipse, TrueBeam, and HyperSight ecosystem increasingly bundles QA tooling, making it a broad incumbent competing for QA budget at customer sites.
- Elekta: Elekta is a global radiation therapy and radiosurgery systems vendor (Elekta Unity MR-Linac, Versa HD, Gamma Knife). As an OEM, it competes with QUASAR by integrating QA workflows and commissioning services around its own linac platforms.
- Accuray: Accuray manufactures CyberKnife and TomoTherapy/Radixact systems and bundles QA tools for its robotic and helical delivery platforms. QUASAR explicitly supports Radixact and CyberKnife, positioning Accuray as both a partner and competitive channel.
- IBA Dosimetry: IBA Dosimetry is the parent product division that owns the QUASAR brand and offers a broader RT QA portfolio (including non-QUASAR products like myQA, MatriXX detectors). It is the immediate corporate parent and the wider portfolio against which QUASAR's offering is positioned.
Emerging players
- Fluke Biomedical / RaySafe: RaySafe (Fluke Biomedical) offers patient dose monitoring and real-time dosimetry solutions for radiation therapy and diagnostic imaging. Its patient dose monitoring line competes with QUASAR's diagnostic imaging and patient dose QA offerings.
- LAP (Laser Applications and Lasers): LAP specializes in patient positioning, laser alignment, and motion-enabling systems used in radiation therapy. It is adjacent to QUASAR's motion management and targeting QA portfolio and overlaps in QA workflows for SGRT and motion-guided RT.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
IBA Quasar social profiles
Digital presenceIBA Quasar financial estimates
Financial estimateRevenue estimate
Valuation estimate
IBA Quasar leadership team
Management profileNumber of profiles
Profiles2 records
IBA Quasar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IBA Quasar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IBA Quasar
What does IBA Quasar do?
IBA Quasar designs and manufactures physical phantoms and accompanying software tools for quality assurance in radiation therapy. The QUASAR portfolio covers MR-guided radiotherapy planning, motion management, IGRT commissioning, IMRT, and geometric distortion analysis, and is sold to medical physicists at cancer treatment centers and hospitals worldwide.
Is IBA Quasar a public or private company?
IBA Quasar is a public company. It is classified as corporate owned and is currently operating.
When was IBA Quasar founded?
IBA Quasar was founded in 2000. It employs 11 to 50 people.
Where is IBA Quasar based?
IBA Quasar is headquartered in London, Canada, in the North America region.
How does IBA Quasar make money?
Three revenue lines are on record. Proton Therapy Systems are the primary driver. The others are dosimetry and QA Equipment and professional Services.
Who are IBA Quasar's main competitors?
Direct peers on record are CIRS (Computerized Imaging Reference Systems), Sun Nuclear (Mirion Medical), Standard Imaging and PTW Dosimetry. Broad incumbents are Varian (Siemens Healthineers), Elekta, Accuray and IBA Dosimetry. Emerging players are Fluke Biomedical / RaySafe and LAP (Laser Applications and Lasers).
Does IBA Quasar have an API?
No public API is recorded for IBA Quasar.
What industry is IBA Quasar in?
IBA Quasar's product category is Radiation Therapy Quality Assurance. Its primary akta.pro industry code is HLACALAL, Quality, Peer Review & Compliance Tools (MQSA/ACR/QA), with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3841.